COMMON STOCK PURCHASE WARRANT MATEON THERAPEUTICS, INC.Common Stock Purchase Warrant • June 13th, 2017 • Mateon Therapeutics Inc • Biological products, (no disgnostic substances) • New York
THIS COMMON STOCK PURCHASE WARRANT` (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 PM New York City time on , 202 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Mateon Therapeutics, Inc., a Delaware corporation (the “Company”), up to shares of common stock, par value $0.01 per share (the “Common Stock”) (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 13th, 2017 • Mateon Therapeutics Inc • Biological products, (no disgnostic substances) • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of , 2017, between Mateon Therapeutics, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
STRICTLY CONFIDENTIAL Mateon Therapeutics, Inc.Letter Agreement • June 13th, 2017 • Mateon Therapeutics Inc • Biological products, (no disgnostic substances) • New York
